Filing detail
Unicycive Therapeutics, Inc. 8-K
Accession 0001213900-25-111045
Filed (ET)
Nov 13, 7:00 PM ET
Accepted
Nov 14, 5:10 PM ET
File size
257.8 KB
SEC accession
0001213900-25-111045
Filing details
- Company
- Unicycive Therapeutics, Inc.
- CIK
- 0001766140
- Incorporated
- DE
- Entity type
- operating
Related parties
- filerCIK 0001766140
Documents
ea0265675-8k_unicycive.htm
8-K
CURRENT REPORT
PrimaryOpen file ↗ea026567502ex1-1_unicycive.htm
EX-1.1
AMENDMENT NO. 1 TO SALES AGREEMENT, DATED NOVEMBER 14, 2025, BETWEEN UNICYCIVE THERAPEUTICS, INC. AND GUGGENHEIM SECURITIES, LLC
ea026567502ex5-1_unicycive.htm
EX-5.1
OPINION OF SHEPPARD MULLIN RICHTER & HAMPTON LLP
ex5-1_001.jpg
GRAPHIC
GRAPHIC
uncy-20251114.xsd
EX-101.SCH
XBRL SCHEMA FILE
uncy-20251114_lab.xml
EX-101.LAB
XBRL LABEL FILE
uncy-20251114_pre.xml
EX-101.PRE
XBRL PRESENTATION FILE
R1.htm
XML
IDEA: XBRL DOCUMENT
Show.js
XML
IDEA: XBRL DOCUMENT
report.css
XML
IDEA: XBRL DOCUMENT
FilingSummary.xml
XML
IDEA: XBRL DOCUMENT
MetaLinks.json
JSON
IDEA: XBRL DOCUMENT
0001213900-25-111045-xbrl.zip
ZIP
IDEA: XBRL DOCUMENT
ea0265675-8k_unicycive_htm.xml
XML
IDEA: XBRL DOCUMENT